Related Experiment Video
Updated: Jun 4, 2026
Production, Purification, and Quality Control for Adeno-associated Virus-based Vectors
Published on: January 29, 2019
Gene Therapy Vectors Harboring AFP Regulatory Sequences : Preparation of an Adenoviral Vector
1First Department of Internal Medicine, Kanazawa University School of Medicine, Kanazawa, Japan.
Abstract:
A goal of cancer research is to develop therapies that can selectively kill tumor cells without adversely affecting normal cells. In the case of hepatocellular carcinoma (HCC), there is a possibility that this goal may be achieved by introducing a cytotoxic gene under the control of transcriptional regulatory sequences of the a-fetoprotein (AFP) gene. The expression of the therapeutic gene should be limited to AFP-positive cells (i.e., HCC), so that only tumor cells will be eliminated without harming normal cells. In this article, we will first review the main features of human AFP regulatory sequences with respect to tumor-specific transcriptional activity. We then describe details of an adenoviral vector carrying the human AFP regulatory sequences used for HCCdirected gene therapy.
Insights
Developing targeted cancer therapies is crucial. This study explores using alpha-fetoprotein (AFP) gene regulatory sequences to control cytotoxic genes, aiming to eliminate hepatocellular carcinoma (HCC) cells specifically.
Area of Science:
- Oncology
- Molecular Biology
- Gene Therapy
Background:
- Developing targeted cancer therapies is a key goal in oncology.
- Hepatocellular carcinoma (HCC) is a major global health concern.
- Selective tumor cell killing without harming normal cells remains a challenge.
Purpose of the Study:
- To investigate the tumor-specific transcriptional activity of human alpha-fetoprotein (AFP) gene regulatory sequences.
- To evaluate the potential of AFP regulatory sequences for directing gene therapy in HCC.
- To describe an adenoviral vector system for HCC-directed gene therapy.
Main Methods:
- Review of human AFP gene regulatory sequences and their transcriptional activity.
- Design and construction of an adenoviral vector.
- Incorporation of AFP regulatory sequences to control a cytotoxic gene within the vector.
Main Results:
- Human AFP regulatory sequences exhibit tumor-specific transcriptional activity, primarily in HCC.
- The adenoviral vector successfully incorporated AFP regulatory sequences.
- The vector is designed for targeted gene expression in AFP-positive HCC cells.
Conclusions:
- AFP regulatory sequences hold promise for achieving tumor-specific gene expression in HCC.
- Adenoviral vectors utilizing AFP regulatory elements offer a potential strategy for targeted HCC gene therapy.
- This approach could lead to more effective and less toxic cancer treatments.
